Guidance for Chief Pharmacists and supporting documents to achieve Institutional Readiness and deployment of Ronapreve

Read first

Implementation of effective process control is essential to ensure that neutralising monoclonal antibody products are implemented safely.

Deployment support for Ronapreve

Getting ready to use casirivimab and imdevimab: guidance for Chief Pharmacists

17 September 2021This guidance for Chief Pharmacists supports the pharmacy institutional readiness for the management of casirivimab and imdevimab in COVID-19 infection.

Handling casirivimab and imdevimab within Trusts

17 September 2021An outline process and supporting materials to help Trusts deploy Ronapreve

Using casirivimab and imdevimab pandemic packs

17 September 2021Initial supplies of casirivimab and imdevimab will be pandemic packs supplied under a Batch Specific Variation to the conditional marketing authorisation

Preparation instructions for individual Ronapreve products

Preparing Casirivimab 600mg Imdevimab 600mg using 2.5mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 600mg Imdevimab 600mg using 11.1mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 1200mg Imdevimab 1200mg using 2.5mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 1200mg Imdevimab 1200mg using 11.1mL Vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve